Filing Flows › Celularity (CELU) › Q4 2024
Celularity (CELU) Q4 2024 earnings results (fourth quarter 2024)
10-K filed May 8, 2025
Celularity (CELU) reported revenue of $18.1M for the fourth quarter 2024 (Q4 2024), +50% from a year earlier and +95% from the quarter before. Operating margin was -51.2%, net loss $13.3M (73.3% of revenue).
Celularity, Q4 2024: revenue $18.1M (+50% year over year), operating margin -51.2%, net loss $13.3M, operating cash flow $1.6M. The chart follows the revenue to costs, profit and cash.
| Q4 2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18.1M | +95% | +50% |
| Operating profit | −$9.3M | — | — |
| Net earnings | −$13.3M | — | — |
| Operating cash flow | $1.6M | — | — |
| Free cash flow | $1.5M | — | — |
What changed
Revenue was $18.1M in Q4 2024, up 50% year over year and up 95% from the previous quarter.
Operating costs exceeded revenue by $9.3M, an operating margin of -51.2%. The quarter ended with a net loss of $13.3M, narrower than the previous quarter's $16.1M loss.
Operating cash flow was $1.6M. Non-cash charges added back $1.9M of depreciation and amortization and $2.9M of share-based compensation. Working capital and other items added $10.1M. Capital expenditures of $56K left free cash flow of $1.5M.
Questions
What was Celularity's revenue in the fourth quarter 2024?
Celularity (CELU) reported revenue of $18.1M for the fourth quarter 2024 (Q4 2024), +50% from a year earlier and +95% from the quarter before.
Was Celularity profitable in the fourth quarter 2024?
Operating loss was $9.3M (-51.2% of revenue) and net loss $13.3M.
Source: Celularity 10-K on SEC EDGAR.